rtki cpd and leuprolide

rtki cpd has been researched along with leuprolide in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Angelucci, C; Iacopino, F; Lama, G; Sica, G1

Other Studies

1 other study(ies) available for rtki cpd and leuprolide

ArticleYear
Leuprorelin acetate affects ERK1/2 activity in prostate cancer cells.
    International journal of oncology, 2006, Volume: 29, Issue:1

    Topics: Antineoplastic Agents, Hormonal; Cell Line, Tumor; Cell Proliferation; Dihydrotestosterone; Dose-Response Relationship, Drug; Epidermal Growth Factor; ErbB Receptors; Humans; Leuprolide; Male; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neoplasms, Hormone-Dependent; Phosphorylation; Prostatic Neoplasms; Protein Kinase Inhibitors; Quinazolines; Time Factors; Tyrphostins

2006